Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Idex (IEX) EBT (2016 - 2026)

Idex has reported EBT over the past 18 years, most recently at $157.0 million for Q1 2026.

  • Quarterly EBT rose 26.1% to $157.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $665.1 million through Mar 2026, up 9.16% year-over-year, with the annual reading at $632.6 million for FY2025, 1.05% down from the prior year.
  • EBT was $157.0 million for Q1 2026 at Idex, down from $167.7 million in the prior quarter.
  • Over five years, EBT peaked at $261.8 million in Q3 2023 and troughed at $124.5 million in Q1 2025.
  • The 5-year median for EBT is $169.9 million (2025), against an average of $172.9 million.
  • Year-over-year, EBT surged 51.16% in 2022 and then tumbled 41.02% in 2024.
  • A 5-year view of EBT shows it stood at $163.5 million in 2022, then decreased by 14.25% to $140.2 million in 2023, then increased by 7.85% to $151.2 million in 2024, then increased by 10.91% to $167.7 million in 2025, then decreased by 6.38% to $157.0 million in 2026.
  • Per Business Quant, the three most recent readings for IEX's EBT are $157.0 million (Q1 2026), $167.7 million (Q4 2025), and $170.5 million (Q3 2025).